XML 44 R38.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Goodwill and Acquisition-Related Intangibles (Tables)
6 Months Ended
Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Summary of Carrying Amount of Goodwill

There was no change in the carrying amount in the six months ended June 30, 2024. Goodwill, net, as of June 30, 2024 and December 31, 2023 by reporting unit was as follows:

 

 

June 30, 2024

 

 

December 31, 2023

 

 

(in thousands)

 

Goodwill, net:

 

 

 

 

 

Laboratory services

$

 

 

$

 

Therapeutic development

 

22,055

 

 

 

22,055

 

Total

$

22,055

 

 

$

22,055

 

Summaries of Goodwill and Acquisitions-Related Intangibles Balances

Summaries of intangible asset balances as of June 30, 2024 and December 31, 2023 were as follows:

 

 

Weighted-Average Amortization Period

June 30, 2024

 

 

December 31, 2023

 

 

 

(in thousands)

 

Laboratory Services:

 

 

 

 

 

 

Royalty-free technology

10 Years

$

5,091

 

 

$

5,211

 

Less: accumulated amortization

 

 

(1,612

)

 

 

(1,390

)

Royalty-free technology, net

 

 

3,479

 

 

 

3,821

 

 

 

 

 

 

 

 

Customer Relationships

13 Years

 

83,092

 

 

 

83,119

 

Less: accumulated amortization

 

 

(15,827

)

 

 

(12,586

)

Customer relationships, net

 

 

67,265

 

 

 

70,533

 

 

 

 

 

 

 

 

Trade name

8 Years

 

3,790

 

 

 

3,790

 

Less: accumulated amortization

 

 

(1,154

)

 

 

(906

)

Trade name, net

 

 

2,636

 

 

 

2,884

 

 

 

 

 

 

 

 

In-place lease intangible assets

5 Years

 

360

 

 

 

360

 

Less: accumulated amortization

 

 

(151

)

 

 

(116

)

In-place lease intangible assets, net

 

 

209

 

 

 

244

 

 

 

 

 

 

 

 

Laboratory information system platform

5 Years

 

1,860

 

 

 

1,860

 

Less: accumulated amortization

 

 

(1,085

)

 

 

(899

)

Laboratory information system platform, net

 

 

775

 

 

 

961

 

 

 

 

 

 

 

 

Purchased patent

10 Years

 

28

 

 

 

28

 

Less: accumulated amortization

 

 

(9

)

 

 

(8

)

Purchased patent, net

 

 

19

 

 

 

20

 

Total

 

 

74,383

 

 

 

78,463

 

 

 

 

 

 

 

 

Therapeutic Development:

 

 

 

 

 

 

In-process research & development

n/a

 

64,590

 

 

 

64,590

 

Total

 

 

64,590

 

 

 

64,590

 

Total intangible assets, net

 

$

138,973

 

 

$

143,053

 

Summary of Annual Amortization Expense For Acquisition-Related Intangibles

Based on the carrying value of finite-lived intangible assets recorded as of June 30, 2024, and assuming no subsequent impairment of the underlying assets, the annual amortization expense for intangible assets is expected to be as follows:

 

 

Amounts

 

 

(in thousands)

 

Year Ending December 31,

 

 

2024 (remaining 6 months)

$

3,979

 

2025

 

7,959

 

2026

 

7,657

 

2027

 

7,198

 

2028

 

7,163

 

2029

 

6,906

 

Thereafter

 

33,521

 

Total

$

74,383